Trial Information

Summary: If you are age 18-75 and are taking daily medication to control your asthma symptoms, you may qualify for participation in a research study to test and investigational medication for people with asthma.

The purpose of this study is to find out if reslizumab is effective ion controlling asthma symptoms. The study will last about 26 weeks and will require 10 visits to the office and phone calls between visits. Qualified participants will receive either placebo or reslizumab on a 1:1 ratio.

Patient Inclusion Criteria:

  • M/F age 18 -75
  • Moderate to severe asthma
* If you pre-qualify and come in to be screened for this study, we will do a physical examination, collect sputum, do breathing tests, get a sinus CT and draw blood for tests to further determine if you qualify for the study.

Patient Exclusion Criteria:

  • Hypereosiniphilic syndrome
  • MI or CVA in the last 3 months
  • Aortic aneurysm
  • Uncontrolled HTN
  • Other lung disorder
  • Current smoker or smoked in the past six months
  • Current use of OCS or immunosupressives
  • Live vaccine in the past three months
  • Acquired or congential immunodeficiency

Contact:

Melanie Schell, FNP-BC, CCRC, AE-C
Toledo Center for Clinical Research (TCCR)
5860 Alexis Rd, Suite B
Sylvania, OH 43560
Telephone: 419-885-5163
Fax: 419-885-1758
Email:

Profile Page: Toledo Center for Clinical Research (TCCR), Sylvania, OH

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:45:17 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA